Article

Osman, Muhammad ORCID: 0000-0003-3818-9729 , van Schalkwyk, Cari, Naidoo, Pren, Seddon, James A., Dunbar, Rory, Dlamini, Sicelo S., Welte, Alex, Hesseling, Anneke C. and Claassens, Mareli M. (2021) Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register. Scientific Reports, 11 (1):15894. ISSN 2045-2322 (Online) (doi:https://doi.org/10.1038/s41598-021-95331-w)

Osman, Muhammad ORCID: 0000-0003-3818-9729 , Meehan, Sue-Ann ORCID: 0000-0002-0826-1833 , von Delft, Arne, Du Preez, Karen, Dunbar, Rory, Marx, Florian M., Boulle, Andrew, Welte, Alex, Naidoo, Pren and Hesseling, Anneke C. (2021) Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa. PLoS ONE, 16 (6):e0252084. ISSN 1932-6203 (Online) (doi:https://doi.org/10.1371/journal.pone.0252084)

Osman, Muhammad ORCID: 0000-0003-3818-9729 , du Preez, Karen, Seddon, James A., Claassens, Mareli M., Dunbar, Rory, Dlamini, Sicelo S., Welte, Alex, Naidoo, Pren and Hesseling, Anneke C. (2021) Mortality in South African children and adolescents routinely treated for tuberculosis. Pediatrics, 147 (4):e2020032490. ISSN 0031-4005 (Print), 1098-4275 (Online) (doi:https://doi.org/10.1542/peds.2020-032490)

Purchase, Susan E., Garcia-Prats, Anthony J., De Koker, Petra, Draper, Heather R., Osman, Muhammad ORCID: 0000-0003-3818-9729 , Seddon, James A., Schaaf, H. Simon and Hesseling, Anneke C. (2019) Acceptability of a novel levofloxacin dispersible tablet formulation in young children exposed to multidrug-resistant tuberculosis. Pediatric Infectious Disease Journal, 38 (6). pp. 608-610. ISSN 0891-3668 (Print), 1532-0987 (Online) (doi:https://doi.org/10.1097/INF.0000000000002268)

Osman, Muhammad ORCID: 0000-0003-3818-9729 , Welte, Alex, Dunbar, Rory, Brown, Rosemary, Hoddinott, Graeme, Hesseling, Anneke C. and Marx, Florian M. (2019) Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study. International Journal of Infectious Diseases, 85. pp. 57-63. ISSN 1201-9712 (doi:https://doi.org/10.1016/j.ijid.2019.05.024)

Osman, Muhammad ORCID: 0000-0003-3818-9729 , Harausz, Elizabeth P., Garcia-Prats, Anthony J., Schaaf, H. Simon, Moore, Brittany K., Hicks, Robert M., Achar, Jay, Amanullah, Farhana, Barry, Pennan, Becerra, Mercedes, Chiotan, Domnica I., Drobac, Peter C., Flood, Jennifer, Furin, Jennifer, Gegia, Medea, Isaakidis, Petros, Mariandyshev, Andrei, Ozere, Iveta, Shah, N. Sarita, Skrahina, Alena, Yablokova, Elena, Seddon, James A. and Hesseling, Anneke C. (2019) Treatment outcomes in global systematic review and patient meta-analysis of children with extensively drug-resistant tuberculosis. Emerging Infectious Diseases, 25 (3). pp. 441-450. ISSN 1080-6040 (Print), 1080-6059 (Online) (doi:https://doi.org/10.3201/eid2503.180852)

Seddon, James A. ORCID: 0000-0002-2296-2302 , Garcia-Prats, Anthony J., Purchase, Susan E., Osman, Muhammad ORCID: 0000-0003-3818-9729 , Demers, Anne-Marie, Hoddinott, Graeme, Crook, Angela M., Owen-Powell, Ellen, Thomason, Margaret J., Turkova, Anna, Gibb, Diana M., Fairlie, Lee, Martinson, Neil, Schaaf, H. Simon and Hesseling, Anneke C. (2018) Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). Trials, 19 (1):693. ISSN 1745-6215 (Online) (doi:https://doi.org/10.1186/s13063-018-3070-0)